Johnson & Johnson has been saying for some time that it thinks its combination of Rybrevant and Lazcluze is the best option for patients with EGFR-mutated non-small cell lung cancer (NSCLC) – and now ...

Johnson & Johnson’s seltorexant is one of two new therapies that the company reckons could become blockbuster treatments for depression, and data from a phase 3 trial keeps that hope alive. Topline ...

If you’re in a situation where Microsoft Outlook and your Outlook Data Files are not opening, and we’re talking about the .pst and .ost files, then there’s an ...

An inherent principle of publication is that others should be able to replicate and build upon the authors' published claims. A condition of publication in a Nature Portfolio journal is that authors ...

A letter allegedly from Jeffrey Epstein to Larry Nassar was included in a recent Justice Department document release. The letter's authenticity is questionable as it was postmarked in Virginia three ...